当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2015年第18期 > 正文
编号:12730831
CYP450酶与中药代谢相互作用及酶活性测定的研究进展(6)
http://www.100md.com 2015年9月15日 《中国中药杂志》2015年第18期
     [46] Breimer D D, Schellens J H. A ″cocktail″ strategy to assess in vivo oxidative drug metabolism in humans[J].Trends Pharmacol Sci, 1990, 11(6): 223.

    [47] Ardjomand W, Kollroser M, Li L, et al. Development and xalidation of a LC-MS/MS method based on a new 96-well Hybrid-SPETM-precipitation technique for quantification of CYP450 substrates metabolitesin ratplasma[J]. Anal bioanal chem, 2011, 400(8): 2371.

    [48] Stewart N A, Buch S C, Conrads T P, et al. A UPLC-MS/MS assay of the "Pitsburgh cocktail":six CYP probe-drug metabolites from human plasma andurine using stable isotope dilution [J]. Analyst, 2011, 136(3): 605.

    [49] Tucker G T, Houston J B, Huang S M. Optimizing drug development: strtegies to assess drug metabolism/transporter interaction potential-toward a consensus [J]. Pharm Res, 2001, 18(8): 1071.

    [50] 胡晓波, 谭蓉. 影响CYP450和P-gp活性的抗菌药物联合用药探讨[J].抗感染药学, 2012, 9(4): 257.

    [51] Palmer J L, Scon R J, Gibson A, et al. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A)[J]. Br J Clin Pharmacol, 2001, 52(5): 555.

    [责任编辑 马超一] (陆兔林 苏联麟 季德 顾薇 毛春芹)
上一页1 2 3 4 5 6